Related Experiment Videos
Glucocorticoids in clinical oncology
1Department of Hematology and Medical Oncology, Cleveland Clinic Cancer Center, OH.
Cleveland Clinic Journal of Medicine
|September 1, 1992
Summary
Glucocorticoids are vital in cancer treatment, particularly for lymphoproliferative disorders and breast cancer, due to their anti-inflammatory effects. However, optimal dosages and toxicity risk factors require further investigation for improved patient outcomes.
Area of Science:
- Oncology
- Pharmacology
Background:
- Glucocorticoids have been utilized in clinical oncology for over 30 years.
- Their anti-inflammatory properties are key to their oncological applications.
- Prednisone and dexamethasone are commonly used, orally absorbed glucocorticoids with similar pharmacokinetics.
Purpose of the Study:
- To review the role of glucocorticoids in clinical oncology.
- To highlight the importance of their anti-inflammatory action.
- To identify gaps in knowledge regarding optimal dosing and toxicity risk factors.
Main Methods:
- Literature review of glucocorticoid use in oncology.
- Analysis of their application in lymphoproliferative disorders and breast cancer.
- Discussion of symptom palliation in advanced cancer.
Main Results:
- Glucocorticoids are integral to treating specific cancers and managing symptoms.
- Optimal dosages and toxicity predictors remain undetermined.
- The relationship between glucocorticoid blood levels and therapeutic effects is not well-defined.
Conclusions:
- Glucocorticoids are essential in oncology, particularly for lymphoproliferative disorders, breast cancer, and symptom management.
- Further research is needed to establish optimal dosing strategies and understand toxicity factors.
- Clarifying the link between drug concentration and clinical response is crucial.